A possible autocrine role for interleukin-6 in two lymphoma cell lines.

Abstract:

:Interleukin-6 (IL-6) is a growth factor with diverse biologic activity. Originally described as a T-cell product that enhances immunoglobulin (Ig) secretion in antigen-stimulated B cells, it also affects the growth of T cells, plasmacytomas, hybridomas, and hematopoietic stem cells. We report the expression and secretion of IL-6 by two lymphoma cell lines, OCI-LY3 and OCI-LY12. Addition of recombinant IL-6 stimulated their growth, whereas addition of polyclonal anti-recombinant IL-6 (anti-rIL-6) had a marked inhibitory effect on proliferation. These results suggest an autocrine role for IL-6 in the growth of these lymphoma cells in culture.

journal_name

Blood

journal_title

Blood

authors

Yee C,Biondi A,Wang XH,Iscove NN,de Sousa J,Aarden LA,Wong GG,Clark SC,Messner HA,Minden MD

subject

Has Abstract

pub_date

1989-08-01 00:00:00

pages

798-804

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

74

pub_type

杂志文章

相关文献

BLOOD文献大全
  • von Willebrand factor-cleaving protease ADAMTS13 reduces ischemic brain injury in experimental stroke.

    abstract::Stroke is a leading cause of death and disability. The only therapy available is recombinant tissue plasminogen activator, but side effects limit its use. Platelets play a crucial role during stroke, and the inflammatory reaction promotes neurodegeneration. von Willebrand factor (VWF), an adhesion molecule for platele...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-213264

    authors: Zhao BQ,Chauhan AK,Canault M,Patten IS,Yang JJ,Dockal M,Scheiflinger F,Wagner DD

    更新日期:2009-10-08 00:00:00

  • Colony-stimulating factor-1-induced oscillations in phosphatidylinositol-3 kinase/AKT are required for caspase activation in monocytes undergoing differentiation into macrophages.

    abstract::The differentiation of human peripheral blood monocytes into resident macrophages is driven by colony-stimulating factor-1 (CSF-1), which upon interaction with CSF-1 receptor (CSF-1R) induces within minutes the phosphorylation of its cytoplasmic tyrosine residues and the activation of multiple signaling complexes. Cas...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2009-03-208843

    authors: Jacquel A,Benikhlef N,Paggetti J,Lalaoui N,Guery L,Dufour EK,Ciudad M,Racoeur C,Micheau O,Delva L,Droin N,Solary E

    更新日期:2009-10-22 00:00:00

  • MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells.

    abstract::The most frequently recurring translocations in mucosa-associated lymphoid tissue (MALT) B-cell non-Hodgkin lymphoma, t(11;18)(q21;q21) and t(14;18)(q32; q21), lead to formation of an API2-MALT1 fusion or IgH-mediated MALT1 overexpression. Various approaches have implicated these proteins in nuclear factor kappaB (NF-...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-06-2297

    authors: Ho L,Davis RE,Conne B,Chappuis R,Berczy M,Mhawech P,Staudt LM,Schwaller J

    更新日期:2005-04-01 00:00:00

  • Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes.

    abstract::CD8+CD25+ cells, which expressed high levels of Foxp3, glucocorticoid-induced tumor necrosis factor receptor (GITR), CCR8, tumor necrosis factor receptor 2 (TNFR2), and cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) mRNAs, were identified in the fibrous septa and medullary areas of human thymus. Activated CD8+CD...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-04-1320

    authors: Cosmi L,Liotta F,Lazzeri E,Francalanci M,Angeli R,Mazzinghi B,Santarlasci V,Manetti R,Vanini V,Romagnani P,Maggi E,Romagnani S,Annunziato F

    更新日期:2003-12-01 00:00:00

  • Interaction of Sp1 with the human gamma globin promoter: binding and transactivation of normal and mutant promoters.

    abstract::We have analyzed the binding of Sp1, a ubiquitously expressed transactivator, to the promoter region of the gamma genes. Low-affinity Sp1 sites were found at -50 and -200. A high-affinity site was detected at -140, over the CACCC sequence. To analyze the function of these sites, Drosophila SL-2 cells, which lack Sp1, ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gumucio DL,Rood KL,Blanchard-McQuate KL,Gray TA,Saulino A,Collins FS

    更新日期:1991-10-01 00:00:00

  • Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice.

    abstract::It has been reported that the intracellular antiapoptotic factor myeloid cell leukemia sequence 1 (Mcl-1) is required for mast cell survival in vitro, and that genetic manipulation of Mcl-1 can be used to delete individual hematopoietic cell populations in vivo. In the present study, we report the generation of C57BL/...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-343962

    authors: Lilla JN,Chen CC,Mukai K,BenBarak MJ,Franco CB,Kalesnikoff J,Yu M,Tsai M,Piliponsky AM,Galli SJ

    更新日期:2011-12-22 00:00:00

  • Perioperative management of patients on chronic antithrombotic therapy.

    abstract::Perioperative management of antithrombotic therapy is a situation that occurs frequently and requires consideration of the patient, the procedure, and an expanding array of anticoagulant and antiplatelet agents. Preoperative assessment must address each patient's risk for thromboembolic events balanced against the ris...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2012-05-423228

    authors: Ortel TL

    更新日期:2012-12-06 00:00:00

  • Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment.

    abstract::Multicentric Castleman disease (MCD) is a lymphoproliferative disorder associated with human herpesvirus 8 (HHV-8) infection among persons with human immunodeficiency virus (HIV) infection. Treatment often includes chemotherapy, and progression to non-Hodgkin lymphoma frequently occurs. MCD is characterized in part by...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-05-1721

    authors: Casper C,Nichols WG,Huang ML,Corey L,Wald A

    更新日期:2004-03-01 00:00:00

  • Aging and obesity augment the stress-induced expression of tissue factor gene in the mouse.

    abstract::Hypercoagulability and thrombotic tendency are frequently induced by a variety of stressors. Clinically, aged subjects and obese patients are more susceptible to thrombotic diseases associated with stress, but the underlying mechanisms are unknown. We investigated the expression of a procoagulant gene, tissue factor (...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-03-0945

    authors: Yamamoto K,Shimokawa T,Yi H,Isobe K,Kojima T,Loskutoff DJ,Saito H

    更新日期:2002-12-01 00:00:00

  • Stem cell transplantation with reduced-intensity conditioning for hemophagocytic lymphohistiocytosis.

    abstract::Allogeneic stem cell transplantation (SCT) is curative for hemophagocytic lymphohistiocytosis (HLH). However, patients frequently have significant morbidity before transplantation and there is high transplant-related mortality (TRM). Because first-degree HLH is caused by immune dysregulation, a reduced-intensity condi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-05-1819

    authors: Cooper N,Rao K,Gilmour K,Hadad L,Adams S,Cale C,Davies G,Webb D,Veys P,Amrolia P

    更新日期:2006-02-01 00:00:00

  • Phase 1 study of weekly dosing with the investigational oral proteasome inhibitor ixazomib in relapsed/refractory multiple myeloma.

    abstract::Proteasome inhibition is an effective treatment strategy for multiple myeloma. With improving survival, attention is increasingly focusing on ease of administration and toxicity profile. Ixazomib is an investigational, orally bioavailable 20S proteasome inhibitor. Sixty patients with relapsed and/or refractory multipl...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-01-548941

    authors: Kumar SK,Bensinger WI,Zimmerman TM,Reeder CB,Berenson JR,Berg D,Hui AM,Gupta N,Di Bacco A,Yu J,Shou Y,Niesvizky R

    更新日期:2014-08-14 00:00:00

  • The T-cell CD2 determinant mediates inhibition of erythropoiesis by the lymphokine cascade.

    abstract::We examined the role of the T-cell antigen CD2 in the regulation of erythropoiesis by the lymphokine cascade. T-cell interleukin-2 (IL-2) receptors (p55) were induced via triggering of the antigen receptor-associated CD3 epitope. Before CD3 triggering T cells were preincubated with a CD2-blocking (Leu-5b) or isotype c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Burdach S,Shatsky M,Wagenhorst B,Levitt L

    更新日期:1988-08-01 00:00:00

  • MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes.

    abstract::MRP14 (S100A9) is the major calcium-binding protein of neutrophils and monocytes. Targeted gene disruption reveals an essential role of this S100 protein for transendothelial migration of phagocytes. The underlying molecular mechanism comprises major alterations of cytoskeletal metabolism. MRP14, in complex with its b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0446

    authors: Vogl T,Ludwig S,Goebeler M,Strey A,Thorey IS,Reichelt R,Foell D,Gerke V,Manitz MP,Nacken W,Werner S,Sorg C,Roth J

    更新日期:2004-12-15 00:00:00

  • Whole-exome sequencing to identify genetic risk variants underlying inhibitor development in severe hemophilia A patients.

    abstract::The development of neutralizing antibodies (inhibitors) against coagulation factor VIII (FVIII) is the most problematic and costly complication of FVIII replacement therapy that affects up to 30% of previously untreated patients with severe hemophilia A. The development of inhibitors is a multifactorial complication i...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-12-685735

    authors: Gorski MM,Blighe K,Lotta LA,Pappalardo E,Garagiola I,Mancini I,Mancuso ME,Fasulo MR,Santagostino E,Peyvandi F

    更新日期:2016-06-09 00:00:00

  • In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation.

    abstract::Expression of B7 family costimulatory molecules on B cells defines their capacity to function as antigen presenting cells (APCs). B cells that do not express B7 costimulatory molecules induce T-cell tolerance. Therefore, the expression of B7 costimulatory molecules on malignant B cells might be critical for their reco...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Dorfman DM,Schultze JL,Shahsafaei A,Michalak S,Gribben JG,Freeman GJ,Pinkus GS,Nadler LM

    更新日期:1997-12-01 00:00:00

  • T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.

    abstract::SCL/tal is a putative oncogene originally identified through its involvement in the translocation t(1;14)(p32;q11) present in the leukemic cell line DU.528. Subsequent studies have shown an upstream deletion activating expression of SCL/tal to be one of the most common genetic lesions in T-cell acute lymphoblastic leu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Goldfarb AN,Goueli S,Mickelson D,Greenberg JM

    更新日期:1992-12-01 00:00:00

  • Mechanism of quinine-dependent monoclonal antibody binding to platelet glycoprotein IIb/IIIa.

    abstract::Drug-dependent antibodies (DDAbs) that cause acute thrombocytopenia upon drug exposure are nonreactive in the absence of the drug but bind tightly to a platelet membrane glycoprotein, usually α(IIb)/β3 integrin (GPIIb/IIIa) when the drug is present. How a drug promotes binding of antibody to its target is unknown and ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-04-643148

    authors: Bougie DW,Peterson J,Rasmussen M,Aster RH

    更新日期:2015-10-29 00:00:00

  • Frontline brentuximab vedotin in combination with dacarbazine or bendamustine in patients aged ≥60 years with HL.

    abstract::Patients aged ≥60 years with treatment-naive Hodgkin lymphoma (HL) have few treatment options and inferior survival due to treatment-related toxicities and comorbidities. This phase 2, nonrandomized, open-label study evaluated brentuximab vedotin (BV) monotherapy (results previously reported), BV plus dacarbazine (DTI...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2017-06-787200

    authors: Friedberg JW,Forero-Torres A,Bordoni RE,Cline VJM,Patel Donnelly D,Flynn PJ,Olsen G,Chen R,Fong A,Wang Y,Yasenchak CA

    更新日期:2017-12-28 00:00:00

  • Aberrant expression of B-lymphocyte stimulator by B chronic lymphocytic leukemia cells: a mechanism for survival.

    abstract::B-cell chronic lymphocytic leukemia (B-CLL) is defined by the accumulation of CD5(+) B cells in the periphery and bone marrow. This disease is not characterized by highly proliferative cells but rather by the presence of leukemic cells with significant resistance to apoptosis and, therefore, prolonged survival. B-lymp...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-02-0558

    authors: Novak AJ,Bram RJ,Kay NE,Jelinek DF

    更新日期:2002-10-15 00:00:00

  • CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia.

    abstract::CCAAT/enhancer binding proteins (C/EBPs) are a family of factors that regulate cell growth and differentiation. These factors, particularly C/EBPalpha and C/EBPepsilon, have important roles in normal myelopoiesis. In addition, loss of C/EBP activity appears to have a role in the pathogenesis of myeloid disorders inclu...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-05-1374

    authors: Truong BT,Lee YJ,Lodie TA,Park DJ,Perrotti D,Watanabe N,Koeffler HP,Nakajima H,Tenen DG,Kogan SC

    更新日期:2003-02-01 00:00:00

  • Ultrastructural localization of nonspecific esterase activity in guinea pig and human monocytes, macrophages, and lymphocytes.

    abstract::Using either hexazotized pararosaniline or new fuchsin as coupling agents, we investigated the ultrastructural localization of alpha-naphthyl acetate esterase (ANAE) activity in guinea pig bone marrow and peritoneal exudates, and in human peripheral blood cells. DFP-inhibitable ANAE activity was present on the cell su...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Monahan RA,Dvorak HF,Dvorak AM

    更新日期:1981-12-01 00:00:00

  • The incidence of chronic lymphocytic leukemia in Taiwan, 1986-2005: a distinct increasing trend with birth-cohort effect.

    abstract::The incidence of chronic lymphocytic leukemia (CLL) in Taiwan is markedly lower than that in Western countries, but we have seen a drastically increasing trend. We explored this distinct incidence trend of CLL for Taiwanese. The epidemiologic data of CLL for Taiwanese and Caucasian Americans during 1986 to 2005 were o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-05-285221

    authors: Wu SJ,Huang SY,Lin CT,Lin YJ,Chang CJ,Tien HF

    更新日期:2010-11-25 00:00:00

  • Proteolytic inactivation of ADAMTS13 by thrombin and plasmin.

    abstract::The multimeric size and the function of circulating von Willebrand factor are modulated via its proteolytic cleavage by the plasma metalloproteinase, ADAMTS13. It is unclear how ADAMTS13 activity is regulated within the vascular system. In the absence of a regulatory mechanism, ADAMTS13 activity might compromise plate...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-03-1101

    authors: Crawley JT,Lam JK,Rance JB,Mollica LR,O'Donnell JS,Lane DA

    更新日期:2005-02-01 00:00:00

  • Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells.

    abstract::Tissue inhibitor of metalloproteinases (TIMP)-1 and TIMP-2 are proteins with proteinase-inhibiting and cytokine properties. TIMP-1 is active primarily in B cells and B-cell lymphomas, whereas TIMP-2 expression is restricted to T cells. The expression of TIMP-1 and TIMP-2 in lymph nodes from patients with Hodgkin disea...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.1.258

    authors: Oelmann E,Herbst H,Zühlsdorf M,Albrecht O,Nolte A,Schmitmann C,Manzke O,Diehl V,Stein H,Berdel WE

    更新日期:2002-01-01 00:00:00

  • MicroRNA-139-5p regulates proliferation of hematopoietic progenitors and is repressed during BCR-ABL-mediated leukemogenesis.

    abstract::MicroRNAs (miRNAs) have emerged as important regulators of the immune system. However, despite this prominence, our understanding of the function of miRNAs in the early hematopoietic stages is incomplete. In this study, we found that miR-139-5p negatively regulated the proliferation of hematopoietic stem cells and pro...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-02-702464

    authors: Choi J,Kim YK,Park K,Nah J,Yoon SS,Kim DW,Kim VN,Seong RH

    更新日期:2016-10-27 00:00:00

  • Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence.

    abstract::Immunosenescence is the functional deterioration of the immune system during natural aging. Despite increased susceptibility to bacterial infections in older adults, age-associated changes to neutrophil responses are only partially understood, and neutrophil migration has not been characterized in detail. Here we desc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-08-519520

    authors: Sapey E,Greenwood H,Walton G,Mann E,Love A,Aaronson N,Insall RH,Stockley RA,Lord JM

    更新日期:2014-01-09 00:00:00

  • Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets.

    abstract::Human blood contains 2 populations of dendritic cells (DCs): plasmacytoid and myeloid (mDC). mDCs are subdivided into 3 subsets using the surface markers CD16, CD1c, and BDCA-3. Their role as pathogen sentinels and adjuvant targets was tested by phenotypic and functional analysis. We show that mDC subsets are immature...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-08-038422

    authors: Piccioli D,Tavarini S,Borgogni E,Steri V,Nuti S,Sammicheli C,Bardelli M,Montagna D,Locatelli F,Wack A

    更新日期:2007-06-15 00:00:00

  • Reduced expression of inducible gelatinase B/matrix metalloproteinase-9 in monocytes from patients with myelodysplastic syndrome: Correlation of inducible levels with the percentage of cytogenetically marked cells and with marrow cellularity.

    abstract::Regulatory molecules produced by stromal cells are often membrane bound until cleaved by matrix metalloproteinases (MMPs); cleavage can either activate or inactivate regulatory functions. We report here that marrow stromal cells induce the expression of MMP-9 in monocytes. Induction was contact independent and could b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-05-020289

    authors: Iwata M,Pillai M,Ramakrishnan A,Hackman RC,Deeg HJ,Opdenakker G,Torok-Storb B

    更新日期:2007-01-01 00:00:00

  • Bleomycin in older early-stage favorable Hodgkin lymphoma patients: analysis of the German Hodgkin Study Group (GHSG) HD10 and HD13 trials.

    abstract::Doxorubicin, bleomycin, vinblastine sulfate, and dacarbazine (ABVD) is associated with severe toxicity in older patients, particularly from bleomycin-induced lung toxicity (BLT). Therefore, using bleomycin has been questioned in older Hodgkin lymphoma (HL) patients, especially in early-stage HL. We therefore analyzed ...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究,随机对照试验

    doi:10.1182/blood-2015-11-681064

    authors: Böll B,Goergen H,Behringer K,Bröckelmann PJ,Hitz F,Kerkhoff A,Greil R,von Tresckow B,Eichenauer DA,Bürkle C,Borchmann S,Fuchs M,Diehl V,Engert A,Borchmann P

    更新日期:2016-05-05 00:00:00

  • Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma.

    abstract::Multiple myeloma (MM) is associated with severe normochromic/normocytic anemia. This study demonstrates that the abnormal up-regulation of apoptogenic receptors, including both Fas ligand (L) and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), by highly malignant myeloma cells is involved in the patho...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.4.1305

    authors: Silvestris F,Cafforio P,Tucci M,Dammacco F

    更新日期:2002-02-15 00:00:00